Updated Jul 16, 2026
RONNEBERG AMY L has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Based on the latest SEC filing context provided (as of 2026-05-22), Amy L. Ronneberg is listed as a Director for Actuate Therapeutics, Inc. Public records or the filing do not reveal additional biographical details such as education, prior positions, or notable achievements beyond her board role at the company. There is no confirmed information in the given context indicating her death.
| Role | Director |
|---|---|
| Notability | 15/100 |
Based on the latest SEC filing context provided (as of 2026-05-22), Amy L. Ronneberg is listed as a Director for Actuate Therapeutics, Inc. Public records or the filing do not reveal additional biographical details such as education, prior positions, or notable achievements beyond her board role at the company. There is no confirmed information in the given context indicating h…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live RONNEBERG AMY L profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.